183 related articles for article (PubMed ID: 8564245)
21. Effects of tachykinins on myenteric neurones of the guinea-pig gastric corpus: involvement of NK-3 receptors.
Schemann M; Kayser H
Pflugers Arch; 1991 Dec; 419(6):566-71. PubMed ID: 1724075
[TBL] [Abstract][Full Text] [Related]
22. Intranigral tachykinin NK3 receptor agonist elicits oral movements in rats.
Liminga U; Johansson PE; Gunne L
Pharmacol Biochem Behav; 1991 Mar; 38(3):617-20. PubMed ID: 1712496
[TBL] [Abstract][Full Text] [Related]
23. Involvement of NK1 receptors and importance of the N-terminal sequence of substance P in the stimulation of protein secretion in rat parotid glands.
Rollandy I; Guillemain I; Imhoff V; Drapeau G; Regoli D; Rossignol B
Eur J Pharmacol; 1991 Dec; 209(1-2):95-100. PubMed ID: 1726089
[TBL] [Abstract][Full Text] [Related]
24. Neuropeptide gamma, the most potent contractile tachykinin in human isolated bronchus, acts via a 'non-classical' NK2 receptor.
Burcher E; Alouan LA; Johnson PR; Black JL
Neuropeptides; 1991 Oct; 20(2):79-82. PubMed ID: 1665897
[TBL] [Abstract][Full Text] [Related]
25. Characterization of NK-1 receptors in guinea pig and rat brain membranes with NK-1 peptides and a non-peptide antagonist.
Tousignant C; Chrétien L; Guillemette G; Regoli D
Brain Res; 1992 Nov; 596(1-2):243-50. PubMed ID: 1281744
[TBL] [Abstract][Full Text] [Related]
26. Injection of tachykinins and selective neurokinin receptor ligands into the substantia nigra reticulata increases striatal dopamine and 5-hydroxytryptamine metabolism.
Humpel C; Saria A; Regoli D
Eur J Pharmacol; 1991 Mar; 195(1):107-14. PubMed ID: 1712305
[TBL] [Abstract][Full Text] [Related]
27. Microvascular leakage induced by substance P in rat urinary bladder: involvement of cyclo-oxygenase metabolites of arachidonic acid.
Abelli L; Nappi F; Perretti F; Maggi CA; Manzini S; Giachetti A
J Auton Pharmacol; 1992 Aug; 12(4):269-76. PubMed ID: 1380964
[TBL] [Abstract][Full Text] [Related]
28. Neurokinin receptors differentially mediate endogenous acetylcholine release evoked by tachykinins in the neostriatum.
Arenas E; Alberch J; Perez-Navarro E; Solsona C; Marsal J
J Neurosci; 1991 Aug; 11(8):2332-8. PubMed ID: 1651375
[TBL] [Abstract][Full Text] [Related]
29. N-terminal substance P fragments inhibit the spinally induced, NK 1 receptor mediated behavioural responses in mice.
Sakurada T; Tan-No K; Yamada T; Sakurada S; Kisara K; Ohba M; Terenius L
Life Sci; 1990; 47(20):PL109-13. PubMed ID: 1701844
[TBL] [Abstract][Full Text] [Related]
30. Tachykinins: effects on gastric secretion and emptying in rats.
Improta G; Broccardo M
Pharmacol Res; 1990; 22(5):605-10. PubMed ID: 2177557
[TBL] [Abstract][Full Text] [Related]
31. Two affinities for a single antagonist at the neuronal NK1 tachykinin receptor: evidence from quantitation of receptor endocytosis.
Jenkinson KM; Southwell BR; Furness JB
Br J Pharmacol; 1999 Jan; 126(1):131-6. PubMed ID: 10051129
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of tachykinin-induced hypotension in dogs by CP-96,345, a selective blocker of NK-1 receptors.
Constantine JW; Lebel WS; Woody HA
Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):471-7. PubMed ID: 1722563
[TBL] [Abstract][Full Text] [Related]
33. [pGlu6,Pro9]SP6-11, a selective agonist for the substance P P-receptor subtype.
Laufer R; Gilon C; Chorev M; Selinger Z
J Med Chem; 1986 Jul; 29(7):1284-8. PubMed ID: 2433445
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of tachykinin NK-1 and NK-3 receptor binding sites in the spinal cord of spontaneously hypertensive rat: impact on the autonomic control of blood pressure.
Cloutier F; Ongali B; Deschamps K; Brouillette J; Neugebauer W; Couture R
Br J Pharmacol; 2006 May; 148(1):25-38. PubMed ID: 16491095
[TBL] [Abstract][Full Text] [Related]
35. Possible existence of a new tachykinin receptor subtype in the guinea pig ileum.
Petitet F; Saffroy M; Torrens Y; Lavielle S; Chassaing G; Loeuillet D; Glowinski J; Beaujouan JC
Peptides; 1992; 13(2):383-8. PubMed ID: 1384010
[TBL] [Abstract][Full Text] [Related]
36. Species differences between [3H] substance P binding in rat and guinea-pig shown by the use of peptide agonists and antagonists.
Fardin V; Garret C
Eur J Pharmacol; 1991 Aug; 201(2-3):231-4. PubMed ID: 1724651
[TBL] [Abstract][Full Text] [Related]
37. Tachykinin receptors mediating airway macromolecular secretion.
Gentry SE
Life Sci; 1991; 48(17):1609-18. PubMed ID: 1708071
[TBL] [Abstract][Full Text] [Related]
38. [Pro9]SP and [pGlu6, Pro9]SP(6-11) interact with two different receptors in the guinea-pig ileum as demonstrated with new SP antagonists.
Chassaing G; Lavielle S; Brunissen A; Carruette A; Garret C; Petitet F; Saffroy M; Beaujouan JC; Torrens Y; Glowinski J
Neuropeptides; 1992 Oct; 23(2):73-9. PubMed ID: 1280787
[TBL] [Abstract][Full Text] [Related]
39. Potentiation of tachykinin-induced plasma protein extravasation by calcitonin gene-related peptide.
Gamse R; Saria A
Eur J Pharmacol; 1985 Aug; 114(1):61-6. PubMed ID: 2412851
[TBL] [Abstract][Full Text] [Related]
40. In vivo pharmacology of [beta Ala8]neurokinin A-(4-10), a selective NK-2 tachykinin receptor agonist.
Maggi CA; Giuliani S; Ballati L; Rovero P; Abelli L; Manzini S; Giachetti A; Meli A
Eur J Pharmacol; 1990 Feb; 177(1-2):81-6. PubMed ID: 2160369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
